US prostate cancer market diagnostics and therapeutics are forecast to augment at a CAGR of 10.4% during the forecast period. The major factors for the growth of the market include the high prevalence of prostate cancer in the country. As per the World Health Organization, in US prostate cancer is the most prevalent cancer among men. Around 212,000 new cases of prostate cancer have been registered in 2018 in the country which is around 18.5% of the overall cancer cases. Moreover, it is the sixth-highest reason for mortality in the country due to cancer. In 2018, around 29,000 mortalities were registered in the country. According to the American Cancer Society, nearly $12 billion in treatment is spent every year for prostate cancer treatment. In addition, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to fuel the market. 

US prostate cancer diagnostic market is segmented on the basis of diagnostic techniques and therapeutics. By diagnostic technique, the market is further divided into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Prostate biopsy is expected to hold a significant market share during the forecast period. By therapeutics, the market is further divided into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. During the forecast period, chemotherapy is expected will hold a major market share in the country. 

The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, Amgen Inc., Ferring Pharmaceuticals Inc., Johnson & Johnson, Siemens Healthcare AG, Amgen Inc., AstraZeneca PLC, Bayer AG, Endo Pharmaceuticals Inc., Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to brings authenticity to the reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug manufacturing companies, medical device manufacturing companies, contract manufacturers, government organizations, and venture capitalists for the comprehensive market analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US Prostate Cancer Market Research and Analysis by Diagnostic Technique
2. US Prostate Cancer Market Research and Analysis by Therapy

The Report Covers

• Comprehensive research methodology of the US Prostate Cancer Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Prostate Cancer Market.
• Insights about market determinants which are stimulating the US Prostate Cancer Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.